封堵器市场规模、份额及成长分析（按产品、应用、最终用户和地区划分）－2026-2033年产业预测

全球闭塞装置市场规模预计在 2024 年达到 30.9 亿美元，从 2025 年的 32.5 亿美元增长到 2033 年的 48.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.1%。

全球血管闭塞装置市场持续稳定成长，主要驱动力是心血管、神经血管和周边血管疾病日益增长的增加。包括栓塞装置和支撑装置在内的各种血管闭塞装置对于有效治疗至关重要。人口老化和微创手术技术的进步也进一步加速了市场成长。血管内治疗（尤其是在门诊手术中心）的日益普及以及对门诊服务需求的增长，都推动了对这些装置的需求。北美地区由于心血管疾病的高发病率和主要行业参与者的存在，占据了市场主导地位。然而，由于医疗基础设施的改善和患者意识的提高，欧洲和亚太地区也经历了快速增长。总体而言，预计该市场将保持持续成长。

全球封堵器市场成长要素

心血管、神经血管和周边血管疾病的日益普遍是推动全球血管闭塞装置市场成长的主要因素。这些疾病需要有效的治疗方案，包括血管闭塞装置，以恢復血流并预防併发症。随着人口老化和不良生活方式等因素导致这些疾病的全球负担加重，对血管闭塞装置的需求也持续增加。这一趋势凸显了开发创新医疗技术以应对健康挑战并改善不同患者群体治疗效果的紧迫性。

限制全球封堵器市场发展的因素

全球血管闭塞器械市场面临严峻的挑战，这主要源于严格的监管核准流程，该流程优先考虑病患安全和产品疗效。从监管机构和其他管道获得必要的核准可能耗时耗力。这些法规的严格性，加上对特定品质标准的要求，为市场参与企业，尤其是中小企业，设置了重重障碍。这些障碍会阻碍市场准入和业务扩张，最终影响产业的竞争格局和创新。

全球封堵器市场趋势

在全球封堵器市场，生物可吸收装置的普及应用已成为一个显着趋势，其驱动力在于市场对能够提升患者舒适度和安全性的创新解决方案的需求日益增长。这些装置旨在被人体自然溶解，无需再次手术取出，并显着降低长期併发症的风险。随着医疗保健不断向以患者为中心和个人化治疗方案发展，製造商正大力投资研发，以改善生物可吸收材料，确保其有效性和安全性。对这些先进的微创治疗方法日益增长的关注正在重塑市场竞争格局。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球封堵器市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 堵塞清除装置
  • 球囊阻塞装置
  • 血栓摘取支架
  • 线圈回收装置
  • 吸痰装置
• 栓塞装置
  • 栓塞线圈
  • 液态栓塞剂
  • 输卵管阻塞装置
• 支援的设备
  • 微导管
  • 导管导引线

全球封堵器市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 神经病学
• 心臟病学
• 週边血管疾病
• 泌尿系统
• 肿瘤学
• 妇科

全球封堵器市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 诊断中心
• 手术中心
• 门诊治疗中心
• 研究机构和学术机构

全球封堵器市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific Corporation（United States）
• Medtronic PLC（Ireland）
• Terumo Corporation（Japan）
• Stryker Corporation（United States）
• Penumbra, Inc.（United States）
• Abbott Laboratories（United States）
• Edwards Lifesciences Corporation（United States）
• Johnson & Johnson（United States）
• Merit Medical Systems, Inc.（United States）
• Lepu Medical Technology Co., Ltd.（China）
• Asahi Intecc Co., Ltd.（Japan）
• AngioDynamics, Inc.（United States）
• Cardinal Health, Inc.（United States）
• Avinger, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• CR Bard, Inc.（United States）
• Cook Medical Incorporated（United States）
• Acrostak International Distribution Sarl（Switzerland）

结论与建议

Global Occlusion Devices Market size was valued at USD 3.09 Billion in 2024 and is poised to grow from USD 3.25 Billion in 2025 to USD 4.83 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global occlusion devices market is undergoing robust expansion, primarily driven by the rise in cardiovascular diseases, neurovascular conditions, and peripheral vascular issues. Various types of occlusion devices, such as embolization and support devices, are essential for effective treatment. Market growth is further propelled by an aging population and advancements in minimally invasive surgical techniques. The increasing adoption of endovascular procedures and rising preference for outpatient services, particularly in ambulatory surgical centers, are enhancing demand for these devices. North America dominates the market share due to a high prevalence of cardiovascular diseases and the presence of major industry players, while Europe and Asia-Pacific are also experiencing rapid growth owing to improved healthcare infrastructure and growing patient awareness. Overall, the market is poised for sustained growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Occlusion Devices Market Segments Analysis

Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Occlusion Devices Market

The increasing prevalence of cardiovascular diseases, neurovascular disorders, and peripheral vascular diseases serves as a major catalyst for the growth of the global occlusion devices market. These medical conditions necessitate effective treatment solutions, including occlusion devices, aimed at restoring blood flow and averting further complications. As the global burden of these disorders rises, driven by factors such as an aging population and deteriorating lifestyle choices, the demand for occlusion devices continues to expand. This trend underscores the urgent need for innovative medical technologies to address these health challenges and improve patient outcomes across diverse populations.

Restraints in the Global Occlusion Devices Market

The Global Occlusion Devices market faces significant challenges due to rigorous regulatory approval processes that prioritize patient safety and product effectiveness. Securing necessary approvals, such as those required from regulatory bodies, can be both a lengthy and expensive endeavor. The demanding nature of these regulations, along with the requirement to adhere to specific quality standards, creates obstacles for market participants, especially for small and medium-sized enterprises. These hurdles can hinder their ability to enter the market or expand their operations, ultimately affecting the competitive landscape and innovation within the industry.

Market Trends of the Global Occlusion Devices Market

The Global Occlusion Devices market is witnessing a notable trend towards the adoption of bioresorbable devices, driven by an increasing demand for innovative solutions that enhance patient comfort and safety. These devices, designed to naturally dissolve within the body, eliminate the need for additional surgical procedures for removal, significantly reducing the risk of long-term complications. As healthcare continues to evolve towards more patient-centric and personalized treatment options, manufacturers are heavily investing in research and development to improve bioresorbable materials and ensure their efficacy and safety. This growing emphasis on advanced, less invasive interventions is reshaping the competitive landscape of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Occlusion Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Occlusion Removal Devices
  • Balloon Occlusion Devices
  • Stent Retrievers
  • Coil Retrievers
  • Suction & Aspiration Devices
• Embolization Devices
  • Embolic Coils
  • Liquid Embolic Agents
  • Tubal Occlusion Devices
• Support Devices
  • Microcatheters
  • Guidewires

Global Occlusion Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Neurology
• Cardiology
• Peripheral Vascular Diseases
• Urology
• Oncology
• Gynecology

Global Occlusion Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers,
• Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes

Global Occlusion Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acrostak International Distribution Sarl (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations